Lipid Therapeutics Licenses Rights to UC Therapy to Nestlé Health Science

News   Sep 21, 2015

 
Lipid Therapeutics Licenses Rights to UC Therapy to Nestlé Health Science
 
 
 

RELATED ARTICLES

Combining Different Malaria Vaccines Could Reduce Cases by 91%

News

Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.

READ MORE

Compound as Effective as FDA-Approved Drugs Against Life-Threatening Infections

News

Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.

READ MORE

Chemists Design 'Mini-ecosystems' to Test Drug Function

News

Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy